Great West Life Assurance CO Intellia Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 25,981 shares of NTLA stock, worth $417,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,981
Previous 27,611
5.9%
Holding current value
$417,254
Previous $759,000
23.32%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding NTLA
# of Institutions
319Shares Held
88.4MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$197 Million2.39% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$154 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$146 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$77.1 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$70.1 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.22B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...